VagiVital has been named a therapeutic vaginal gel since it has been proven to do much more than simply moisturize. VagiVital has undergone a multi-centre clinical study on 90 patients, documenting safe and positive results. Led by a group of female scientists, professors and practicing gynecologists at Karolinska University Hospital, Uppsala University Hospital and Umeå University Hospital in Sweden, a total of 79% of patients experienced complete relief or a significant improvement in their most persistent symptoms.
The following results have been proven:
- Complete relief or significant improvement of most common symptoms (itching, irritation, stinging, discomfort during sexual intercourse or urination)
- Reduced sense of urgency to urinate
- Improvement of vaginal pH and increase of superficial cells in the vaginal tissue.
The positive effects of VagiVital are on par with those reported for most estrogen preparations, with one important difference: VagiVital is completely hormone-free.
The study was designed according to FDA guidelines.